In this episode of the NeuroOp Guru in collaboration with Ophthalmology Times, host Andrew G. Lee, MD, is joined by Drew Carey, MD, to discuss pretreatment features associated with vision improvement ...
PRIME designation follows recent Breakthrough Therapy designation from the U.S. FDA, underscoring the importance and urgency of addressing optic ...
Traumatic injury to the brain, spinal cord and optic nerve in the central nervous system (CNS) are the leading cause of disability and the second leading cause of death worldwide. CNS injuries often ...
Privosegtor has received PRIME designation in Europe for the treatment of optic neuritis, a condition commonly seen in ...
Traumatic injury to the brain, spinal cord and optic nerve in the central nervous system (CNS) are the leading cause of disability and the second leading cause of death worldwide. CNS injuries often ...
TORONTO and HAIFA, Israel, May 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a preclinical-stage biotechnology company ...
TORONTO and HAIFA, Israel, July 17, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (NRX:CA), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company, is ...
When your optic nerve doesn’t develop all the way, you may not be able to see through that area of your eye. This congenital condition is most often experienced by people who have mothers with ...
Please provide your email address to receive an email when new articles are posted on . A 65-year-old woman presented to the New England Eye Center with 4 weeks of decreased vision and 6 months of ...
Prospective assessment of renal function using cystatin C and functional MRI in children with newly diagnosed renal tumors. A combination chemotherapy, temozolomide (TMZ) with etoposide (VP), in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results